Perfil
Daniel A. Simon is Chief Business Officer at IDEAYA Biosciences, Inc. since 2024.
Formerly, Chief Business Officer at Revolution Medicines, Inc. from 2022 to 2024.
Senior VP-Biopharma Business Development at Guardant Health, Inc. from 2015 to 2022.
Education includes graduate studies at the University of Cambridge and an MBA from The Wharton School of the University of Pennsylvania.
Cargos activos de Daniel Simon
| Empresas | Cargo | Inicio |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/08/2024 |
Antiguos cargos conocidos de Daniel Simon.
| Empresas | Cargo | Fin |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 01/01/2024 |
| GUARDANT HEALTH, INC. | Corporate Officer/Principal | 01/01/2022 |
Formación de Daniel Simon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Daniel Simon
















